Health technology assessment process of a cardiovascular medical device in four different settings

• Published in: Journal of comparative effectiveness research Vol. 6; no. 7; pp. 591 - 600
• Main Authors: Olry de Labry Lima, Antonio, Espín Balbino, Jaime, Lemgruber, Alexandre, Caro Martínez, Araceli, García-Mochón, Leticia, Martín Ruiz, Eva, Lessa, Fernanda
• Format: Journal Article
• Language: English
• Published: England Future Medicine Ltd 01-10-2017
• Subjects: cardiology/cardiovascular; comparative effectiveness research; Comparative Effectiveness Research - economics; Costs and Cost Analysis; Cross-Sectional Studies; Decision Making; Drug-Eluting Stents - economics; health technology assessment; Humans; Reimbursement Mechanisms - economics; Technology Assessment, Biomedical - methods; health technology assessment; comparative effectiveness research; cardiology/cardiovascular
• ISSN: 2042-6305; 2042-6313
• DOI: 10.2217/cer-2016-0098

Health technology assessment (HTA) is a tool to help the decision-making process. The aim is to describe methods and processes used in the reimbursement decision making for drug-eluting stents (DES) in four different settings.
DES as a technology under study was selected according to different criteria, all of them agreed by a working group. A survey of key informants was designed.
DES was evaluated following well-structured HTA processes. Nonetheless, scope for improvement was observed in relation to the data considered for the final decision, the transparency and inclusiveness of the process as well as in the methods employed.
An attempt to describe the HTA processes of a well-known medical device.